Marrone Bio Innovations Investor Relations Material
Latest events
Q1 2022
Marrone Bio Innovations
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Marrone Bio Innovations Inc
Access all reports
Marrone Bio Innovations, Inc. develops beneficial bacillus products for crop yield, quality, and performance. The company's products are manufactured from naturally occurring soil bacteria that have been used as microbial pesticides to control pests such as nematodes, insects, and mites. Its products include Regalia, Great Lakes BioSystems' proprietary plant-based bacillus formula for enhancing plant growth and controlling fungal disease; Grandevo, a biopesticide containing three different strains of beneficial bacilli for controlling insect pests and diseases; and Majestene, an insecticide containing various biopesticides to suppress nematode populations.
Latest articles
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
MBII
Country
🇺🇸 United States